Echo IQ Limited (EIQ.AX) Stock Analysis & Winston Score
Echo IQ Limited is an Australian technology company that builds artificial intelligence software for analyzing heart scans. Its main product helps doctors read echocardiograms — ultrasound images of the heart — faster and more accurately. The company sells its tools to hospitals and cardiology clinics, primarily in Australia and the United States. Echo IQ makes money by licensing its software to healthcare providers, though it is still in an early stage and is not yet profitable. The deeply negative margins reflect a pre-revenue or near-zero-revenue business that is spending heavily on development and regulatory approvals. Getting clearance from health regulators like the US FDA is the central hurdle the company must clear to grow, and failure to secure or maintain those approvals would be the biggest risk to its future.
Winston Score: 14/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Weak (2/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: 1.54 AUD
Market Cap: 1.1B AUD
Sector: Basic Materials
Industry: Other Precious Metals
Exchange: Australian Securities Exchange
